alnylam
Alnylam is seeking a highly motivated Senior Scientist in Analytical Development with expertise in bioassays, cell-based assays, qPCR, and ELISA. The role involves performing and overseeing bioassay method development, testing, validation, and supporting external laboratories, contributing to a fast-paced biotech environment.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2002
Alnylam is a biopharmaceutical company that has pioneered RNA interference (RNAi) therapeutics, an innovative class of medicines that treats diseases by silencing the genes that cause or contribute to them. The company develops RNAi-based medicines targeting both rare and prevalent diseases across multiple therapeutic areas, with approved products and a robust investigational pipeline. Driven by science and inspired by patients, Alnylam is committed to delivering transformational medicines that address diseases at their genetic source.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for alnylam.
18% above the average for this role
QC BioAssay/Biochemical Assay Scientist
WuXi Biologics
Analytical Technology Specialist
AbbVie
Bioassay Analyst
Eurofins
Bioassay Scientist, Analytical Research & Development
MSD
Senior Advisor, Bioassay Development — Analytical Development
Eli Lilly and Company
Scientist II, Analytical Development
Aurion Biotech